Copyright © 2012 Diana R. Engineer and Jose M. Garcia. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. J. L. Halaas, K. S. Gajiwala, M. Maffei et al., “Weight-reducing effects of the plasma protein encoded by the obese gene,” Science, vol. 269, no. 5223, pp. 543–546, 1995. View at Scopus
2. J. M. Friedman, “A tale of two hormones,” Nature Medicine, vol. 16, no. 10, pp. 1100–1106, 2010. View at Publisher · View at Google Scholar · View at PubMed
3. J. M. Friedman, “Modern science versus the stigma of obesity,” Nature Medicine, vol. 10, no. 6, pp. 563–569, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
4. J. S. Flier and E. Maratos-Flier, “Lasker lauds leptin,” Cell, vol. 143, no. 1, pp. 9–12, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
5. W. A. Banks, “Enhanced leptin transport across the blood-brain barrier by α1-adrenergic agents,” Brain Research, vol. 899, no. 1-2, pp. 209–217, 2001. View at Publisher · View at Google Scholar · View at Scopus
6. W. A. Banks, “Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations,” Current Pharmaceutical Design, vol. 9, no. 10, pp. 801–809, 2003. View at Publisher · View at Google Scholar · View at Scopus
7. W. A. Banks and C. L. Farrell, “Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible,” American Journal of Physiology, vol. 285, no. 1, pp. E10–E15, 2003.
8. A. J. Kastin and W. Pan, “Dynamic regulation of leptin entry into brain by the blood-brain barrier,” Regulatory Peptides, vol. 92, no. 1–3, pp. 37–43, 2000. View at Publisher · View at Google Scholar · View at Scopus
9. S. Margetic, C. Gazzola, G. G. Pegg, and R. A. Hill, “Leptin: a review of its peripheral actions and interactions,” International Journal of Obesity, vol. 26, no. 11, pp. 1407–1433, 2002. View at Publisher · View at Google Scholar · View at PubMed
10. W. Doehner, C. D. Pflaum, M. Rauchhaus et al., “Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia,” European Journal of Endocrinology, vol. 145, no. 6, pp. 727–735, 2001. View at Scopus
11. W. Doehner and S. D. Anker, “Cardiac cachexia in early literature: a review of research prior to Medline,” International Journal of Cardiology, vol. 85, no. 1, pp. 7–14, 2002. View at Publisher · View at Google Scholar · View at Scopus
12. W. M. Mueller, F. M. Gregoire, K. L. Stanhope et al., “Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes,” Endocrinology, vol. 139, no. 2, pp. 551–558, 1998. View at Publisher · View at Google Scholar · View at Scopus
13. P. Leroy, S. Dessolin, P. Villageois et al., “Expression of ob gene in adipose cells: regulation by insulin,” Journal of Biological Chemistry, vol. 271, no. 5, pp. 2365–2368, 1996. View at Scopus
14. C. S. Mantzoros and S. J. Moschos, “Leptin: in search of role(s) in human physiology and pathophysiology,” Clinical Endocrinology, vol. 49, no. 5, pp. 551–567, 1998. View at Publisher · View at Google Scholar · View at Scopus
15. A. Khan, S. Narangoda, B. Ahren, C. Holm, F. Sundler, and S. Efendic, “Long-term leptin treatment of ob/ob mice improves glucose-induced insulin secretion,” International Journal of Obesity, vol. 25, no. 6, pp. 816–821, 2001.
16. C. Koch, R. A. Augustine, J. Steger et al., “Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity,” Journal of Neuroscience, vol. 30, no. 48, pp. 16180–16187, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
17. J. W. Lee and D. R. Romsos, “Leptin administration normalizes insulin secretion from islets of Lep^ob/Lep^ob mice by food intake-dependent and -independent mechanisms,” Experimental Biology and Medicine, vol. 228, no. 2, pp. 183–187, 2003. View at Scopus
18. M. W. Schwartz, D. G. Baskin, T. R. Bukowski et al., “Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice,” Diabetes, vol. 45, no. 4, pp. 531–535, 1996. View at Scopus
19. M. A. Pelleymounter, M. J. Cullen, M. B. Baker et al., “Effects of the obese gene product on body weight regulation in ob/ob mice,” Science, vol. 269, no. 5223, pp. 540–543, 1995. View at Scopus
20. C. T. Montague, I. S. Farooqi, J. P. Whitehead et al., “Congenital leptin deficiency is associated with severe early-onset obesity in humans,” Nature, vol. 387, no. 6636, pp. 903–908, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
21. K. Clément, C. Vaisse, N. Lahlou et al., “A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction,” Nature, vol. 392, no. 6674, pp. 398–401, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
22. R. V. Considine, M. K. Sinha, M. L. Heiman et al., “Serum immunoreactive-leptin concentrations in normal-weight and obese humans,” New England Journal of Medicine, vol. 334, no. 5, pp. 292–295, 1996. View at Publisher · View at Google Scholar · View at Scopus
23. B. Burguera, M. E. Couce, G. L. Curran et al., “Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats,” Diabetes, vol. 49, no. 7, pp. 1219–1223, 2000. View at Scopus
24. J. F. Caro, J. W. Kolaczynski, M. R. Nyce et al., “Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance,” The Lancet, vol. 348, no. 9021, pp. 159–161, 1996. View at Publisher · View at Google Scholar · View at Scopus
25. S. P. Kalra, “Circumventing leptin resistance for weight control,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 8, pp. 4279–4281, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
26. S. P. Kalra, M. G. Dube, S. Pu, B. Xu, T. L. Horvath, and P. S. Kalra, “Interacting appetite-regulating pathways in the hypothalamic regulation of body weight,” Endocrine Reviews, vol. 20, no. 1, pp. 68–100, 1999. View at Publisher · View at Google Scholar · View at Scopus
27. M. W. Schwartz, E. Peskind, M. Raskind, E. J. Boyko, and D. Porte Jr., “Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans,” Nature Medicine, vol. 2, no. 5, pp. 589–593, 1996. View at Publisher · View at Google Scholar · View at Scopus
28. L. A. Campfield, F. J. Smith, Y. Guisez, R. Devos, and P. Burn, “Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks,” Science, vol. 269, no. 5223, pp. 546–549, 1995. View at Scopus
29. M. G. Dube, E. Beretta, H. Dhillon, N. Ueno, P. S. Kalra, and S. P. Kalra, “Central leptin gene therapy blocks high-fat diet-induced weight gain, hyperleptinemia, and hyperinsulinemia: increase in serum ghrelin levels,” Diabetes, vol. 51, no. 6, pp. 1729–1736, 2002. View at Scopus
30. J. L. Halaas, C. Boozer, J. Blair-West, N. Fidahusein, D. A. Denton, and J. M. Friedman, “Physiological response to long-term peripheral and central leptin infusion in lean and obese mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 16, pp. 8878–8883, 1997. View at Publisher · View at Google Scholar · View at Scopus
31. P. A. Baldock, A. Sainsbury, S. Allison et al., “Hypothalamic control of bone formation: distinct actions of leptin and Y2 receptor pathways,” Journal of Bone and Mineral Research, vol. 20, no. 10, pp. 1851–1857, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
32. H. Dhillon, S. P. Kalra, V. Prima et al., “Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study,” Regulatory Peptides, vol. 99, no. 2-3, pp. 69–77, 2001. View at Publisher · View at Google Scholar · View at Scopus
33. A. J. Kastin and V. Akerstrom, “Fasting, but not adrenalectomy, reduces transport of leptin into the brain,” Peptides, vol. 21, no. 5, pp. 679–682, 2000. View at Publisher · View at Google Scholar · View at Scopus
34. A. J. Kastin and V. Akerstrom, “Glucose and insulin increase the transport of leptin through the blood-brain barrier in normal mice but not in streptozotocin-diabetic mice,” Neuroendocrinology, vol. 73, no. 4, pp. 237–242, 2001. View at Publisher · View at Google Scholar · View at Scopus
35. K. Chen, F. Li, J. Li et al., “Induction of leptin resistance through direct interaction of C-reactive protein with leptin,” Nature Medicine, vol. 12, no. 4, pp. 425–432, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
36. H. Florez, S. Castillo-Florez, A. Mendez et al., “C-reactive protein is elevated in obese patients with the metabolic syndrome,” Diabetes Research and Clinical Practice, vol. 71, no. 1, pp. 92–100, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
37. E. Beretta, M. G. Dube, P. S. Kalra, and S. P. Kalra, “Long-term suppression of weight gain, adiposity, and serum insulin by central leptin gene therapy in prepubertal rats: effects on serum ghrelin and appetite-regulating genes,” Pediatric Research, vol. 52, no. 2, pp. 189–198, 2002. View at Publisher · View at Google Scholar · View at Scopus
38. S. Boghossian, N. Ueno, M. G. Dube, P. Kalra, and S. Kalra, “Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin,” Neurobiology of Aging, vol. 28, no. 10, pp. 1594–1604, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
39. J. P. Bastard, C. Jardel, E. Bruckert et al., “Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 9, pp. 3338–3342, 2000. View at Scopus
40. I. Wernstedt, B. Olsson, M. Jernås et al., “Increased levels of acylation-stimulating protein in interleukin-6- deficient (IL-6^-/-) mice,” Endocrinology, vol. 147, no. 6, pp. 2690–2695, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
41. K. Stenlöf, I. Wernstedt, T. Fjällman, V. Wallenius, K. Wallenius, and J. O. Jansson, “Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 9, pp. 4379–4383, 2003. View at Publisher · View at Google Scholar
42. G. A. Bray and D. A. York, “Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis,” Physiological Reviews, vol. 59, no. 3, pp. 719–809, 1979. View at Scopus
43. B. K. Anand and J. R. Brobeck, “Localization of a "feeding center" in the hypothalamus of the rat,” Proceedings of the Society for Experimental Biology and Medicine, vol. 77, no. 2, pp. 323–324, 1951.
44. M. A. Cowley, J. L. Smart, M. Rubinstein et al., “Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus,” Nature, vol. 411, no. 6836, pp. 480–484, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
45. N. Ibrahim, M. A. Bosch, J. L. Smart et al., “Hypothalamic proopiomelanocortin neurons are glucose responsive and express KATP channels,” Endocrinology, vol. 144, no. 4, pp. 1331–1340, 2003. View at Publisher · View at Google Scholar · View at Scopus
46. T. L. Horvath, F. Naftolin, S. P. Kalra, and C. Leranth, “Neuropeptide-Y innervation of β-endorphin-containing cells in the rat mediobasal hypothalamus: a light and electron microscopic double immunostaining analysis,” Endocrinology, vol. 131, no. 5, pp. 2461–2467, 1992. View at Publisher · View at Google Scholar · View at Scopus
47. T. L. Horvath, L. M. Garcia-Segura, and F. Naftolin, “Control of gonadotropin feedback: the possible role of estrogen-induced hypothalamic synaptic plasticity,” Gynecological Endocrinology, vol. 11, no. 2, pp. 139–143, 1997. View at Scopus
48. T. L. Horvath, Z. B. Andrews, and S. Diano, “Fuel utilization by hypothalamic neurons: roles for ROS,” Trends in Endocrinology and Metabolism, vol. 20, no. 2, pp. 78–87, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
49. S. Diano, “New aspects of melanocortin signaling: a role for PRCP in α-MSH degradation,” Frontiers in Neuroendocrinology, vol. 32, no. 1, pp. 70–83, 2011. View at Publisher · View at Google Scholar · View at PubMed
50. A. Hinney, A. Schmidt, K. Nottebom et al., “Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 4, pp. 1483–1486, 1999.
51. C. Vaisse, K. Clement, E. Durand, S. Hercberg, B. Guy-Grand, and P. Froguel, “Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity,” Journal of Clinical Investigation, vol. 106, no. 2, pp. 253–262, 2000. View at Scopus
52. A. Sahu, “Minireview: a hypothalamic role in energy balance with special emphasis on leptin,” Endocrinology, vol. 145, no. 6, pp. 2613–2620, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
53. S. Pinto, A. G. Roseberry, H. Liu et al., “Rapid rewiring of arcuate nucleus feeding circuits by leptin,” Science, vol. 304, no. 5667, pp. 110–115, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
54. Y. Maejima, U. Sedbazar, S. Suyama et al., “Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway,” Cell Metabolism, vol. 10, no. 5, pp. 355–365, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
55. D. Walsh, S. Donnelly, and L. Rybicki, “The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients,” Supportive Care in Cancer, vol. 8, no. 3, pp. 175–179, 2000. View at Scopus
56. W. D. Dewys, C. Begg, P. T. Lavin, et al., “Prognostic effect of weight loss prior to chemotherapy in cancer patients,” American Journal of Medicine, vol. 69, no. 4, pp. 491–497, 1980.
57. P. O'Gorman, D. C. McMillan, and C. S. McArdle, “Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients,” Nutrition and Cancer, vol. 32, no. 2, pp. 76–80, 1998. View at Scopus
58. M. J. Tisdale, “Cachexia in cancer patients,” Nature Reviews Cancer, vol. 2, no. 11, pp. 862–871, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
59. C. R. Plata-Salamán, “Cytokines and feeding,” International Journal of Obesity, vol. 25, supplement 5, pp. S48–S52, 2001. View at Publisher · View at Google Scholar
60. A. Laviano, M. M. Meguid, and F. Rossi-Fanelli, “Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies,” The Lancet Oncology, vol. 4, no. 11, pp. 686–694, 2003. View at Publisher · View at Google Scholar · View at Scopus
61. M. E. Martignoni, P. Kunze, and H. Friess, “Cancer cachexia,” Molecular Cancer, vol. 2, article 36, 2003. View at Publisher · View at Google Scholar · View at PubMed
62. S. R. Broussard, R. H. Mccusker, J. E. Novakofski et al., “Cytokine-hormone interactions: tumor necrosis factor α impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts,” Endocrinology, vol. 144, no. 7, pp. 2988–2996, 2003. View at Publisher · View at Google Scholar · View at Scopus
63. R. A. Frost and C. H. Lang, “Alteration of somatotropic function by proinflammatory cytokines,” Journal of Animal Science, vol. 82, pp. E100–E109, 2004. View at Scopus
64. G. H. Lee, R. Proenca, J. M. Montez et al., “Abnormal splicing of the leptin receptor in diabetic mice,” Nature, vol. 379, no. 6566, pp. 632–635, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
65. M. W. Schwartz and G. J. Morton, “Keeping hunger at bay,” Nature, vol. 418, no. 6898, pp. 595–597, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
66. C. Grunfeld, C. Zhao, J. Fuller et al., “Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters,” Journal of Clinical Investigation, vol. 97, no. 9, pp. 2152–2157, 1996. View at Scopus
67. B. E. Wisse, K. Ogimoto, G. J. Morton et al., “Physiological regulation of hypothalamic IL-1β gene expression by leptin and glucocorticoids: implications for energy homeostasis,” American Journal of Physiology, vol. 287, no. 6, pp. E1107–E1113, 2004. View at Publisher · View at Google Scholar · View at PubMed
68. G. N. Luheshi, J. D. Gardner, D. A. Rushforth, A. S. Loudon, and N. J. Rothwell, “Leptin actions on food intake and body temperature are mediated by IL-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 12, pp. 7047–7052, 1999. View at Publisher · View at Google Scholar · View at Scopus
69. V. Sergeyev, C. Broberger, and T. Hökfelt, “Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus,” Molecular Brain Research, vol. 90, no. 2, pp. 93–100, 2001. View at Publisher · View at Google Scholar · View at Scopus
70. D. L. Marks, N. Ling, and R. D. Cone, “Role of the central melanocortin system in cachexia,” Cancer Research, vol. 61, no. 4, pp. 1432–1438, 2001. View at Scopus
71. G. Mantovani, A. Macciò, L. Mura et al., “Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites,” Journal of Molecular Medicine, vol. 78, no. 10, pp. 554–561, 2000. View at Publisher · View at Google Scholar · View at Scopus
72. H. Baumann and J. Gauldie, “The acute phase response,” Immunology Today, vol. 15, no. 2, pp. 74–80, 1994. View at Publisher · View at Google Scholar · View at Scopus
73. A. Laviano, M. M. Meguid, Z. J. Yang, J. R. Gleason, C. Cangiano, and F. R. Fanelli, “Cracking the riddle of cancer anorexia,” Nutrition, vol. 12, no. 10, pp. 706–710, 1996. View at Scopus
74. P. G. Jang, C. Namkoong, G. M. Kang et al., “NF-κB activation in hypothalamic pro-opiomelanocortin neurons is essential in illness- and leptin-induced anorexia,” Journal of Biological Chemistry, vol. 285, no. 13, pp. 9706–9715, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
75. J. P. Thaler, S. J. Choi, M. W. Schwartz, and B. E. Wisse, “Hypothalamic inflammation and energy homeostasis: resolving the paradox,” Frontiers in Neuroendocrinology, vol. 31, no. 1, pp. 79–84, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
76. V. Mohamed-Ali, S. Goodrick, A. Rawesh et al., “Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 12, pp. 4196–4200, 1997. View at Scopus
77. F. Kim, M. Pham, E. Maloney et al., “Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 11, pp. 1982–1988, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
78. C. T. De Souza, E. P. Araujo, S. Bordin et al., “Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus,” Endocrinology, vol. 146, no. 10, pp. 4192–4199, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
79. K. A. Posey, D. J. Clegg, R. L. Printz et al., “Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet,” American Journal of Physiology, vol. 296, no. 5, pp. E1003–E1012, 2009. View at Publisher · View at Google Scholar · View at PubMed
80. X. Zhang, G. Zhang, H. Zhang, M. Karin, H. Bai, and D. Cai, “Hypothalamic IKKβ/NF-κB and ER stress link overnutrition to energy imbalance and obesity,” Cell, vol. 135, no. 1, pp. 61–73, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
81. L. Ozcan, A. S. Ergin, A. Lu et al., “Endoplasmic reticulum stress plays a central role in development of leptin resistance,” Cell Metabolism, vol. 9, no. 1, pp. 35–51, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
82. M. Milanski, G. Degasperi, A. Coope et al., “Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity,” Journal of Neuroscience, vol. 29, no. 2, pp. 359–370, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
83. M. Burstow, T. Kelly, S. Panchani et al., “Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis,” Diseases of the Esophagus, vol. 22, no. 6, pp. 519–525, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
84. H. Suzuki, H. Hashimoto, M. Kawasaki et al., “Similar changes of hypothalamic feeding-regulating peptides mRNAs and plasma leptin levels in PTHrP-, LIF-secreting tumors-induced cachectic rats and adjuvant arthritic rats,” International Journal of Cancer, vol. 128, no. 9, pp. 2215–2223, 2011. View at Publisher · View at Google Scholar · View at PubMed
85. Q. Ding, T. Mracek, P. Gonzalez-Muniesa et al., “Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes,” Endocrinology, vol. 150, no. 4, pp. 1688–1696, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
86. B. Weryńska, M. Kosacka, M. Gołecki, and R. Jankowska, “Leptin serum levels in cachectic and non-cachectic lung cancer patients,” Pneumonologia i Alergologia Polska, vol. 77, no. 6, pp. 500–506, 2009.
87. J. Smiechowska, A. Utech, G. Taffet, T. Hayes, M. Marcelli, and J. M. Garcia, “Adipokines in patients with cancer anorexia and cachexia,” Journal of Investigative Medicine, vol. 58, no. 3, pp. 554–559, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
88. C. Bing, S. Taylor, M. J. Tisdale, and G. Williams, “Cachexia in MAC16 adenocarcinoma: suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y,” Journal of Neurochemistry, vol. 79, no. 5, pp. 1004–1012, 2001. View at Publisher · View at Google Scholar · View at Scopus
89. A. Macciò, C. Madeddu, D. Massa et al., “Interleukin-6 and leptin as markers of energy metabolicchanges in advanced ovarian cancer patients,” Journal of Cellular and Molecular Medicine, vol. 13, no. 9, pp. 3951–3959, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
90. P. Costelli, N. Carbo, L. Tessitore et al., “Tumor necrosis factor-α mediates changes in tissue protein turnover in a rat cancer cachexia model,” Journal of Clinical Investigation, vol. 92, no. 6, pp. 2783–2789, 1993. View at Scopus
91. R. M. Goldberg, C. L. Loprinzi, J. A. Mailliard et al., “Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial,” Journal of Clinical Oncology, vol. 13, no. 11, pp. 2856–2859, 1995. View at Scopus
92. E. Bruera, C. M. Neumann, E. Pituskin, K. Calder, G. Ball, and J. Hanson, “Thalidomide in patients with cachexia due to terminal cancer: preliminary report,” Annals of Oncology, vol. 10, no. 7, pp. 857–859, 1999. View at Publisher · View at Google Scholar · View at Scopus
93. K. Mori, K. Fujimoto-Ouchi, T. Ishikawa, F. Sekiguchi, H. Ishitsuka, and Y. Tanaka, “Murine interleukin-12 prevents the development of cancer cachexia in a murine model,” International Journal of Cancer, vol. 67, no. 6, pp. 849–855, 1996. View at Scopus
94. N. Carbó, J. López-Soriano, P. Costelli et al., “Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats,” British Journal of Cancer, vol. 83, no. 4, pp. 526–531, 2000.
95. G. Mantovani, A. MacCiò, C. Madeddu et al., “Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia,” Journal of Molecular Medicine, vol. 88, no. 1, pp. 85–92, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
96. S. D. Anker, A. Negassa, A. J. S. Coats et al., “Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study,” The Lancet, vol. 361, no. 9363, pp. 1077–1083, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
97. S. D. Anker, P. Ponikowski, S. Varney et al., “Wasting as independent risk factor for mortality in chronic heart failure,” The Lancet, vol. 349, no. 9058, pp. 1050–1053, 1997. View at Publisher · View at Google Scholar · View at Scopus
98. C. R. Gibbs, G. Jackson, and G. Y. H. Lip, “ABC of heart failure: non-drug management,” British Medical Journal, vol. 320, no. 7231, pp. 366–369, 2000. View at Scopus
99. B. Levine, J. Kalman, L. Mayer, H. M. Fillit, and M. Packer, “Elevated circulating levels of tumor necrosis factor in severe chronic heart failure,” New England Journal of Medicine, vol. 323, no. 4, pp. 236–241, 1990. View at Scopus
100. G. S. Filippatos, K. Tsilias, K. Venetsanou et al., “Leptin serum levels in cachectic heart failure patient. Relationship with tumor necrosis factor-α system,” International Journal of Cardiology, vol. 76, no. 2-3, pp. 117–122, 2000. View at Publisher · View at Google Scholar · View at Scopus
101. D. R. Murdoch, E. Rooney, H. J. Dargie, D. Shapiro, J. J. Morton, and J. J. V. McMurray, “Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure,” Heart, vol. 82, no. 3, pp. 352–356, 1999. View at Scopus
102. M. J. Toth, S. S. Gottlieb, M. L. Fisher, A. S. Ryan, B. J. Nicklas, and E. T. Poehlman, “Plasma leptin concentrations and energy expenditure in heart failure patients,” Metabolism, vol. 46, no. 4, pp. 450–453, 1997. View at Publisher · View at Google Scholar · View at Scopus
103. G. Paolisso, M. R. Rizzo, G. Mazziotti et al., “Lack of association between changes in plasma leptin concentration and in food intake during the menstrual cycle,” European Journal of Clinical Investigation, vol. 29, no. 6, pp. 490–495, 1999. View at Publisher · View at Google Scholar · View at Scopus
104. M. W. Nickola, L. E. Wold, P. B. Colligan, G. J. Wang, W. K. Samson, and J. Ren, “Leptin attenuates cardiac contraction in rat ventricular myocytes role of NO,” Hypertension, vol. 36, no. 4, pp. 501–505, 2000. View at Scopus
105. K. R. McGaffin, C. S. Moravec, and C. F. McTiernan, “Leptin signaling in the failing and mechanically unloaded human heart,” Circulation, vol. 2, no. 6, pp. 676–683, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
106. P. C. Schulze, J. Kratzsch, A. Linke et al., “Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure,” European Journal of Heart Failure, vol. 5, no. 1, pp. 33–40, 2003. View at Publisher · View at Google Scholar · View at Scopus
107. F. Leyva, S. D. Anker, K. Egerer, J. C. Stevenson, W. J. Kox, and A. J. S. Coats, “Hyperleptinaemia in chronic heart failure. Relationships with insulin,” European Heart Journal, vol. 19, no. 10, pp. 1547–1551, 1998. View at Publisher · View at Google Scholar · View at Scopus
108. T. Tsutamoto, T. Hisanaga, A. Wada et al., “Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure,” Journal of the American College of Cardiology, vol. 31, no. 2, pp. 391–398, 1998. View at Publisher · View at Google Scholar · View at Scopus
109. V. Sharma and J. H. McNeill, “The emerging roles of leptin and ghrelin in cardiovascular physiology and pathophysiology,” Current Vascular Pharmacology, vol. 3, no. 2, pp. 169–180, 2005. View at Publisher · View at Google Scholar · View at Scopus
110. W. G. Haynes, W. I. Sivitz, D. A. Morgan, S. A. Walsh, and A. L. Mark, “Sympathetic and cardiorenal actions of leptin,” Hypertension, vol. 30, no. 3, pp. 619–623, 1997. View at Scopus
111. W. G. Haynes, D. A. Morgan, S. A. Walsh, W. I. Sivitz, and A. L. Mark, “Cardiovascular consequences of obesity: role of leptin,” Clinical and Experimental Pharmacology and Physiology, vol. 25, no. 1, pp. 65–69, 1998.
112. G. Lembo, C. Vecchione, L. Fratta et al., “Leptin induces direct vasodilation through distinct endothelial mechanisms,” Diabetes, vol. 49, no. 2, pp. 293–297, 2000. View at Scopus
113. S. D. Anker and S. Von Haehling, “Inflammatory mediators in chronic heart failure: an overview,” Heart, vol. 90, no. 4, pp. 464–470, 2004. View at Scopus
114. R. Ferrari, T. Bachetti, R. Confortini et al., “Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure,” Circulation, vol. 92, no. 6, pp. 1479–1486, 1995. View at Scopus
115. M. Rauchhaus, W. Doehner, D. P. Francis et al., “Plasma cytokine parameters and mortality in patients with chronic heart failure,” Circulation, vol. 102, no. 25, pp. 3060–3067, 2000. View at Scopus
116. T. G. Kirchgessner, K. T. Uysal, S. M. Wiesbrock, M. W. Marino, and G. S. Hotamisligil, “Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes,” Journal of Clinical Investigation, vol. 100, no. 11, pp. 2777–2782, 1997. View at Scopus
117. D. Kovačić, M. Marinšek, L. Gobec, M. Lainščak, and M. Podbregar, “Effect of selective and non-selective β-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure,” Clinical Research in Cardiology, vol. 97, no. 1, pp. 24–31, 2008. View at Publisher · View at Google Scholar · View at PubMed
118. Y. Schutz and V. Woringer, “Obesity in switzerland: a critical assessment of prevalence in children and adults,” International Journal of Obesity, vol. 26, supplement 2, pp. S3–S11, 2002.
119. M. K. Sridhar, R. Carter, M. E. J. Lean, and S. W. Banham, “Resting energy expenditure and nutritional state of patients with increased oxygen cost of breathing due to emphysema, scoliosis and thoracoplasty,” Thorax, vol. 49, no. 8, pp. 781–785, 1994. View at Scopus
120. O. Hugli, Y. Schutz, and J. W. Fitting, “The cost of breathing in stable chronic obstructive pulmonary disease,” Clinical Science, vol. 89, no. 6, pp. 625–632, 1995. View at Scopus
121. M. Di Francia, D. Barbier, J. L. Mege, and J. Orehek, “Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 150, no. 5, pp. 1453–1455, 1994. View at Scopus
122. I. De Godoy, M. Donahoe, W. J. Calhoun, J. Mancino, and R. M. Rogers, “Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 2, pp. 633–637, 1996. View at Scopus
123. P. Sarraf, R. C. Frederich, E. M. Turner et al., “Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia,” Journal of Experimental Medicine, vol. 185, no. 1, pp. 171–175, 1997. View at Publisher · View at Google Scholar · View at Scopus
124. M. S. Zumbach, M. W. J. Boehme, P. Wahl, W. Stremmel, R. Ziegler, and P. P. Nawroth, “Tumor necrosis factor increases serum leptin levels in humans,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 12, pp. 4080–4082, 1997.
125. N. Takabatake, H. Nakamura, S. Abe et al., “Circulating leptin in patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 4, pp. 1215–1219, 1999. View at Scopus
126. N. Takabatake, H. Nakamura, O. Minamihaba et al., “A novel pathophysiologic phenomenon in cachexic patients with chronic obstructive pulmonary disease: the relationship between the circadian rhythm of circulating leptin and the very low-frequency component of heart rate variability,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 6, pp. 1314–1319, 2001. View at Scopus
127. C. P. O'Donnell, C. D. Schaub, A. S. Haines et al., “Leptin prevents respiratory depression in obesity,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 5, pp. 1477–1484, 1999. View at Scopus
128. C. G. Tankersley, C. O'Donnell, M. J. Daood et al., “Leptin attenuates respiratory complications associated with the obese phenotype,” Journal of Applied Physiology, vol. 85, no. 6, pp. 2261–2269, 1998. View at Scopus
129. H. Groeben, S. Meier, R. H. Brown, C. P. O'Donnell, W. Mitzner, and C. G. Tankersley, “The effect of leptin on the ventilatory response to hyperoxia,” Experimental Lung Research, vol. 30, no. 7, pp. 559–570, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
130. C. Tankersley, S. Kleeberger, B. Russ, A. Schwartz, and P. Smith, “Modified control of breathing in genetically obese (ob/ob) mice,” Journal of Applied Physiology, vol. 81, no. 2, pp. 716–723, 1996. View at Scopus
131. A. Grosfeld, J. André, S. H.-D. Mouzon, E. Berra, J. Pouysségur, and M. Guerre-Millo, “Hypoxia-inducible factor 1 transactivates the human leptin gene promoter,” Journal of Biological Chemistry, vol. 277, no. 45, pp. 42953–42957, 2002. View at Publisher · View at Google Scholar · View at PubMed
132. S. Budweiser, F. Heinemann, K. Meyer, P. J. Wild, and M. Pfeifer, “Weight gain in cachectic COPD patients receiving noninvasive positive-pressure ventilation,” Respiratory Care, vol. 51, no. 2, pp. 126–132, 2006. View at Scopus
133. K. J. Tracey, “The inflammatory reflex,” Nature, vol. 420, no. 6917, pp. 853–859, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
134. R. H. Mak, W. Cheung, R. D. Cone, and D. L. Marks, “Leptin and inflammation-associated cachexia in chronic kidney disease,” Kidney International, vol. 69, no. 5, pp. 794–797, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
135. W. W. Cheung, K. H. Paik, and R. H. Mak, “Inflammation and cachexia in chronic kidney disease,” Pediatric Nephrology, vol. 25, no. 4, pp. 711–724, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
136. A. Scholze, D. Rattensperger, W. Zidek, and M. Tepel, “Low serum leptin predicts mortality in patients with chronic kidney disease stage 5,” Obesity, vol. 15, no. 6, pp. 1617–1622, 2007. View at Publisher · View at Google Scholar · View at PubMed
137. I. Beberashvili, I. Sinuani, A. Azar et al., “Longitudinal study of leptin levels in chronic hemodialysis patients,” Nutrition Journal, vol. 10, article 68, no. 1, 2011. View at Publisher · View at Google Scholar · View at PubMed
138. P. Stenvinkel, “Leptin—a new hormone of definite interest for the nephrologist,” Nephrology Dialysis Transplantation, vol. 13, no. 5, pp. 1099–1101, 1998. View at Publisher · View at Google Scholar · View at Scopus
139. A. Aguilera, J. A. Sánchez-Tomero, and R. Selgas, “Brain activation in uremic anorexia,” Journal of Renal Nutrition, vol. 17, no. 1, pp. 57–61, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
140. A. F. Suffredini, G. Fantuzzi, R. Badolato, J. J. Oppenheim, and N. P. O'Grady, “New insights into the biology of the acute phase response,” Journal of Clinical Immunology, vol. 19, no. 4, pp. 203–214, 1999. View at Publisher · View at Google Scholar · View at Scopus
141. R. Pecoits-Filho, L. C. Sylvestre, and P. Stenvinkel, “Chronic kidney disease and inflammation in pediatric patients: from bench to playground,” Pediatric Nephrology, vol. 20, no. 6, pp. 714–720, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
142. K. Kalantar-Zadeh, P. Stenvinkel, L. Pillon, and J. D. Kopple, “Inflammation and nutrition in renal insufficiency,” Advances in Renal Replacement Therapy, vol. 10, no. 3, pp. 155–169, 2003. View at Scopus
143. R. H. Mak and W. Cheung, “Energy homeostasis and cachexia in chronic kidney disease,” Pediatric Nephrology, vol. 21, no. 12, pp. 1807–1814, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
144. R. H. Mak and W. Cheung, “Adipokines and gut hormones in end-stage renal disease,” Peritoneal Dialysis International, vol. 27, supplement 2, pp. S298–S302, 2007.
145. W. Cheung, P. X. Yu, B. M. Little, R. D. Cone, D. L. Marks, and R. H. Mak, “Role of leptin and melanocortin signaling in uremia-associated cachexia,” Journal of Clinical Investigation, vol. 115, no. 6, pp. 1659–1665, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
146. P. J. Scarpace, M. Matheny, R. L. Moore, and N. Tümer, “Impaired leptin responsiveness in aged rats,” Diabetes, vol. 49, no. 3, pp. 431–435, 2000.
147. T. Wolden-Hanson, “Mechanisms of the anorexia of aging in the Brown Norway rat,” Physiology and Behavior, vol. 88, no. 3, pp. 267–276, 2006. View at Publisher · View at Google Scholar · View at PubMed
148. E. W. Shek and P. J. Scarpace, “Resistance to the anorexic and thermogenic effects of centrally administrated leptin in obese aged rats,” Regulatory Peptides, vol. 92, no. 1–3, pp. 65–71, 2000. View at Publisher · View at Google Scholar
149. D. A. Gruenewald, M. A. Naai, B. T. Marck, and A. M. Matsumoto, “Age-related decrease in neuropeptide-Y gene expression in the arcuate nucleus of the male rat brain is independent of testicular feedback,” Endocrinology, vol. 134, no. 6, pp. 2383–2389, 1994. View at Publisher · View at Google Scholar
150. D. Horrillo, J. Sierra, C. Arribas et al., “Age-associated development of inflammation in Wistar rats: effects of caloric restriction,” Archives of Physiology and Biochemistry, vol. 117, no. 3, pp. 140–150, 2011. View at Publisher · View at Google Scholar · View at PubMed
151. J. J. Carrero, A. Nakashima, A. R. Qureshi et al., “Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients,” Kidney International, vol. 79, no. 7, pp. 749–756, 2011. View at Publisher · View at Google Scholar · View at PubMed
152. A. van Tellingen, M. P. C. Grooteman, M. Schoorl et al., “Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers,” Nephrology Dialysis Transplantation, vol. 19, no. 5, pp. 1198–1203, 2004. View at Publisher · View at Google Scholar · View at PubMed
153. E. D. Javor, E. K. Cochran, C. Musso, J. R. Young, A. M. DePaoli, and P. Gorden, “Long-term efficacy of leptin replacement in patients with generalized lipodystrophy,” Diabetes, vol. 54, no. 7, pp. 1994–2002, 2005. View at Publisher · View at Google Scholar
154. A. B. Newman, D. Yanez, T. Harris, A. Duxbury, P. L. Enright, and L. P. Fried, “Weight change in old age and its association with mortality,” Journal of the American Geriatrics Society, vol. 49, no. 10, pp. 1309–1318, 2001. View at Publisher · View at Google Scholar
155. G. Hauser and M. Neumann, “Aging with quality of life—a challenge for society,” Journal of Physiology and Pharmacology, vol. 56, supplement 2, pp. 35–48, 2005.
156. Z. Kmiec, “Central regulation of food intake in ageing,” Journal of Physiology and Pharmacology, vol. 57, supplement 6, pp. 7–16, 2006.
157. C. Fernández-Galaz, T. Fernández-Agulló, F. Campoy et al., “Decreased leptin uptake in hypothalamic nuclei with ageing in Wistar rats,” Journal of Endocrinology, vol. 171, no. 1, pp. 23–32, 2001. View at Publisher · View at Google Scholar
158. D. A. Gruenewald, B. T. Marck, and A. M. Matsumoto, “Fasting-induced increases in food intake and neuropeptide Y gene expression are attenuated in aging male brown Norway rats,” Endocrinology, vol. 137, no. 10, pp. 4460–4467, 1996. View at Publisher · View at Google Scholar
159. T. Wolden-Hanson, B. T. Marck, and A. M. Matsumoto, “Blunted hypothalamic neuropeptide gene expression in response to fasting, but preservation of feeding responses to AgRP in aging male Brown Norway rats,” American Journal of Physiology, vol. 287, no. 1, pp. R138–R146, 2004. View at Publisher · View at Google Scholar · View at PubMed
160. O. Bouillanne, C. Dupont-Belmont, P. Hay, B. Hamon-Vilcot, L. Cynober, and C. Aussel, “Fat mass protects hospitalized elderly persons against morbidity and mortality,” American Journal of Clinical Nutrition, vol. 90, no. 3, pp. 505–510, 2009. View at Publisher · View at Google Scholar · View at PubMed
161. Y. Arai, M. Takayama, Y. Abe, and N. Hirose, “Adipokines and aging,” Journal of Atherosclerosis and Thrombosis, vol. 18, no. 7, pp. 545–550, 2011. View at Publisher · View at Google Scholar
162. M. Zamboni, E. Zoico, F. Fantin et al., “Relation between leptin and the metabolic syndrome in elderly women,” Journals of Gerontology, vol. 59, no. 4, pp. 396–400, 2004.
163. P. J. Enriori, A. E. Evans, P. Sinnayah et al., “Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons,” Cell Metabolism, vol. 5, no. 3, pp. 181–194, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
164. R. E. Hubbard, M. S. O, B. L. Calver, and K. W. Woodhouse, “Nutrition, inflammation, and leptin levels in aging and frailty,” Journal of the American Geriatrics Society, vol. 56, no. 2, pp. 279–284, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus